These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 15788587
21. Multimodality imaging of hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Shahbazian H, Mirza-Aghazadeh-Attari M, Borhani A, Mohseni A, Madani SP, Ansari G, Pawlik TM, Kamel IR. J Surg Oncol; 2023 Sep; 128(4):519-530. PubMed ID: 37439096 [Abstract] [Full Text] [Related]
22. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma. Huang XW, Huang Y, Chen LD, Wang Z, Yang Z, Liu JY, Xie XY, Lu MD, Shen SL, Wang W. J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791 [Abstract] [Full Text] [Related]
23. CT features of an intraductal polypoid mass: Differentiation between hepatocellular carcinoma with bile duct tumor invasion and intraductal papillary cholangiocarcinoma. Jung AY, Lee JM, Choi SH, Kim SH, Lee JY, Kim SW, Han JK, Choi BI. J Comput Assist Tomogr; 2006 Apr; 30(2):173-81. PubMed ID: 16628028 [Abstract] [Full Text] [Related]
24. The Growing Interest in the Combined Hepatocellular-intrahepatic Cholangiocarcinoma (cHCC-CCA). Acalovschi M. J Gastrointestin Liver Dis; 2023 Jun 22; 32(2):135-138. PubMed ID: 37345590 [No Abstract] [Full Text] [Related]
26. Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging. Kim JH, Joo I, Lee JM. Korean J Radiol; 2019 Jul 22; 20(7):1019-1041. PubMed ID: 31270973 [Abstract] [Full Text] [Related]
27. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver. Dong Y, Chen S, Möller K, Qiu YJ, Lu XY, Zhang Q, Dietrich CF, Wang WP. Ultrasound Med Biol; 2023 Aug 22; 49(8):1780-1788. PubMed ID: 37156676 [Abstract] [Full Text] [Related]
28. Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines. Barreiros AP, Piscaglia F, Dietrich CF. J Hepatol; 2012 Oct 22; 57(4):930-2. PubMed ID: 22739095 [No Abstract] [Full Text] [Related]
29. Dual-energy CT based material decomposition to differentiate intrahepatic cholangiocarcinoma from hepatocellular carcinoma. Mahmoudi S, Bernatz S, Althoff FC, Koch V, Grünewald LD, Scholtz JE, Walter D, Zeuzem S, Wild PJ, Vogl TJ, Kinzler MN. Eur J Radiol; 2022 Nov 22; 156():110556. PubMed ID: 36270195 [Abstract] [Full Text] [Related]
30. Editorial for "Comparing Survival Outcomes of Patients With LI-RADS-M Hepatocellular Carcinomas and Intrahepatic Cholangiocarcinomas". Yoon JH. J Magn Reson Imaging; 2023 Jan 22; 57(1):318-319. PubMed ID: 35604010 [No Abstract] [Full Text] [Related]
31. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. Tillich M, Mischinger HJ, Preisegger KH, Rabl H, Szolar DH. AJR Am J Roentgenol; 1998 Sep 22; 171(3):651-8. PubMed ID: 9725291 [Abstract] [Full Text] [Related]
32. Computed Tomography Radiomics to Differentiate Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma. Mahmoudi S, Bernatz S, Ackermann J, Koch V, Dos Santos DP, Grünewald LD, Yel I, Martin SS, Scholtz JE, Stehle A, Walter D, Zeuzem S, Wild PJ, Vogl TJ, Kinzler MN. Clin Oncol (R Coll Radiol); 2023 May 22; 35(5):e312-e318. PubMed ID: 36804153 [Abstract] [Full Text] [Related]
33. Transcatheter CT arterial portography and CT hepatic arteriography for liver tumor visualization during percutaneous ablation. van Tilborg AA, Scheffer HJ, Nielsen K, van Waesberghe JH, Comans EF, van Kuijk C, van den Tol PM, Meijerink MR. J Vasc Interv Radiol; 2014 Jul 22; 25(7):1101-1111.e4. PubMed ID: 24755086 [Abstract] [Full Text] [Related]
34. Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Distinguishing Hepatocellular Carcinoma From Cholangiocarcinoma in Pre-Liver Transplantation Evaluation. Lin CC, Cheng YF, Chiang HJ, Lazo M, Chang CD, Tsang LL, Yu CY, Hsu HW, Chen WT, Wang CC, Liang JL, Eng HL, Chen CL, Ou HY. Transplant Proc; 2016 May 22; 48(4):1041-4. PubMed ID: 27320551 [Abstract] [Full Text] [Related]
35. Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. Iavarone M, Piscaglia F, Vavassori S, Galassi M, Sangiovanni A, Venerandi L, Forzenigo LV, Golfieri R, Bolondi L, Colombo M. J Hepatol; 2013 Jun 22; 58(6):1188-93. PubMed ID: 23485522 [Abstract] [Full Text] [Related]
37. Dynamic contrast-enhanced ultrasound (DCE-US) for the characterization of hepatocellular carcinoma and cholangiocellular carcinoma. Wildner D, Pfeifer L, Goertz RS, Bernatik T, Sturm J, Neurath MF, Strobel D. Ultraschall Med; 2014 Dec 22; 35(6):522-7. PubMed ID: 25202903 [Abstract] [Full Text] [Related]
38. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma. Sammon J, Fischer S, Menezes R, Hosseini-Nik H, Lewis S, Taouli B, Jhaveri K. Cancer Imaging; 2018 Feb 27; 18(1):8. PubMed ID: 29486800 [Abstract] [Full Text] [Related]
39. A Ring in the Liver. Xu J, Liang X, Cai X. Am J Gastroenterol; 2021 Jan 01; 116(1):220-222. PubMed ID: 32868632 [No Abstract] [Full Text] [Related]
40. Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging. Kim R, Lee JM, Shin CI, Lee ES, Yoon JH, Joo I, Kim SH, Hwang I, Han JK, Choi BI. Eur Radiol; 2016 Jun 01; 26(6):1808-17. PubMed ID: 26373763 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]